According to Gartner, 30% of internal medical implants and devices in the medical field will use 3D printing technology by the year 2020. Considering China has become world’s 2nd larget medical device market, it is no surprise to us that the new strategic partnership formed by Stratasys and GE Healthcare China will help the Chinese healthcare industry move fast toward with this trend.
The widespread use of 3D printing technology in the medical field can bring great benefits to Chinese patients. The main applications include:
Indeed, China is one of the fastest growing markets for 3D printing in the world.
China Med Device believes this partnership is a win-win situation and will benefit 3D printing technology into the mainstream of China’s healthcare market, giving that Stratasys is a global leader in 3D printing and additive manufacturing solutions and GE Healthcare is the world’s leading provider of medical products and services that provide state-of-the-art medical equipment and services to healthcare organizations. Particularly worth mentioning is that GE Healthcare has just released the GE AW4.7 workstation, which can quickly convert CT scan data and 3D modeling, and then sent directly to the 3D printer for production, and has excellent upstream and downstream device compatibility Sex. With the Stratasys J750 full-color, multi-material 3D printer, you can virtually simulate various tissue characteristics in one print based on real patient imaging data. The partnership will allow GE Healthcare’s imaging data conversion technology to be seamlessly integrated with Stratasys 3D printing technology to provide healthcare organizations with a complete solution for leaps in medical services.